Skip to main content
Signal8

Beroni Group Ltd (BNIGF)

Beroni Group is an international biopharmaceutical enterprise dedicated to the innovation and commercialization of drugs and therapies to combat various global diseases such as cancer and infectious diseases. Its diversified portfolio is comprised of FDA/CE approved virus diagnostic kits, an e-commerce platform for the sale of pharmaceutical products, and a development pipeline targeting oncology and cell therapies. The company has operations in Australia, the United States, China, and Japan.

Sector: Pharmaceutical Preparations

Industry: Biotechnology

Beroni Group Limited logo

Beroni Group Limited

OTC:BNIGFHealthcare
Mkt Cap-
Float59K
O/S-
Inst Own-
Dilution
Historical Data
DateOpenHighLowCloseVolume
Key Metrics
Market Cap--
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership--
SectorHealthcare
IndustryBiotechnology
ExchangeOTC
CountryAUAU
IPO Date-
Shares Outstanding-
Float59,173
Company Overview

Beroni Group is an international biopharmaceutical enterprise dedicated to the innovation and commercialization of drugs and therapies to combat various global diseases such as cancer and infectious diseases.

Its diversified portfolio is comprised of FDA/CE approved virus diagnostic kits, an e-commerce platform for the sale of pharmaceutical products, and a development pipeline targeting oncology and cell therapies.

The company has operations in Australia, the United States, China, and Japan.

Leadership

Boqing Zhang

Founder, Executive Chairman, MD & Chief Executive Officer

Yap Ting Wong

Chief Financial Officer & Executive Director

Hai Huang

Group Chief Operating Officer, Founder & Executive Director

Chen Chik Ong ACIS ACSA FCIS

Non-Executive Director & Company Secretary

Employees

--

Country

AU

Sector

Healthcare

Website

beronigroup.com

Analyst Coverage
No analyst coverage for this companyNo ratings, price targets, or covering firms on file.
Insider Trades
No insider transactions for this companyForeign private issuers and non-reporting entities don't file Form 4/5.
Shareholders
--
Institutional
(0)
--
Insiderⓘ
(0)
--
5%+ Owners
(0)
--
Unattributed (incl. retail)ⓘ
Sources:
52-Week Range
Volume
Average Daily Volume27

30d Avg

27

60d Avg

27

90d Avg

27

Earnings
Dividend History
No dividend history available
Compliance Status
Loading compliance data...